Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ROMA | EFX |
|---|---|---|
| Price | $8.74 | $142.43 |
| Change today | ▲ 0.00% | ▼ 0.04% |
| Market cap | $520.59M | $16.73B |
| Return, 3 months | +2.1% | -14.3% |
| Return, year to date | +417.2% | -33.8% |
| Return, 1 year | +217.8% | -39.9% |
| P/E (TTM) | -128.5 | 25.0 |
| P/B | 54.6 | 3.8 |
| P/E percentile vs own 5y | 6th | 2nd |
| Dividend yield | – | 1.49% |
| Revenue growth (YoY, latest qtr) | -22.2% | +10.6% |
| Net profit growth (YoY) | +1.6% | -3.9% |
| Gross margin | 17.1% | 55.5% |
| Operating margin | -315.0% | 17.9% |
| Net margin | -287.8% | 10.7% |
| Return on equity | -44.2% | 14.6% |
| Analyst target vs. price | – | +47.2% |
| Analyst buy share | – | 75% |
| RSI (14) | 47 | 29 |
| 30-day volatility | 41.9% | 32.6% |
| Max drawdown, 1 year | -61.2% | -45.9% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
